The Malaysian Journal of Analytical Sciences
Vol 17 No 1 (2013): 193 – 199
LIPIDIZATION OF SIMPLE AND DI-FUNCTIONAL AMINO
ACIDS
(Penglipidan Asid
Amino Ringkas dan Dwi-Fungsi)
Zainab
Idris, Mohd. Wahid Samsudin* and Salmiah Ahmad
School of Chemical Sciences and Food
Technology, Faculty of Science and Technology
Universiti Kebangsaan Malaysia, 43600
UKM Bangi, Selangor, Malaysia
*Corresponding author: wahid@ukm.my
Abstract
This
paper discuss the modification of azelaic acid into its applicable form by attachment
of both its carboxyl sites to N-terminal of amino acid ethyl ester forming amide linkages in anhydrous medium. Acylation
of glycine ethyl ester hydrochloride with azelaic acid dichloride was best
conducted in a 100% anhydrous medium. L-amino acid ethyl ester bearing a
primary hydroxyl group on its side chain gave mixtures of product and variation
in composition depending on the mole ratio of reactants used. Reduction in
purity was also observed for L-amino acid ethyl ester with primary –SH group on
its side chain as compared to L-amino acid ethyl ester having –SCH3
group on the L-amino acid side chain. The diamidoester of azelaic acid with
L-alanine ethyl ester, L-valine ethyl ester, L-leucine ethyl ester and
L-glutamic acid diethyl ester were in good yield when prepared through the
modified Schotten-Baumann reaction conditions.
Keywords: Azelaic acid dichloride, L-amino acid ethyl ester,
Schotten-Bauman condition, Glycine ethyl ester hydrochloride
References
1.
Addo-Boadu, K., Wojta, J. Christ,
G, Itufnagl, P., Pehamberger, H. and Binder, B.R. (1996). Azelaic acid
decreases the fibronolytic potential of cultured human melanoma cells in vitro.
Cancer Lett. 103(2):125-129
2.
Bojar, R.A., Cunliffe, W.J. and
Holland, K.T. (1994). Distruption of the transmembrane pH gradient- a possible
mechanism for the antibacterial action of azelaic acid in Propionibacterium
acnes and Staphylococcus epidermis. Journal of Antimicrobial Chemotheraphy.
34:321-330.
3.
Thiboutot, D. (2000). New treatment
and therapeutic strategies for Acne. Arch Fam. Med. 9(2):174-187.
4.
Gollnick, H. P. M and Krautheim,
A. (2003). Topical Treatment in Acne: Current Status and Future Aspects.
Dermatology. 206:29-36.
5.
Akamatsu, H., Komura, J., Asada,
Y., Miyachi, Y. and Niwa, Y. (1991). Inhibitory effect of azelaic acid on
neutrophil functions: a possible cause for its efficacy in treating
phatogenetically unrelated diseases. Arch Dermatol. Res. 283:162-166.
6.
Webster, G. (2000). Combination
of azelaic acid therapy for Acne vulgaris. J. Am. Acad Dermatol 43(2 pt
3):S47-50.
7.
Hermanns, J.F., Petit, L,
Piérard-Frachchimont, C., Paquet, P. and Piérard, G.E. (2002). Assessment of
Topical Hypopigmenting agents on Solar Lentigenes of Asian. Dermatology.
204:281-286.
8.
Maralmadi, G. and Esposito, M.
(2002). Potassium azeloyl diglycinate. Cosmetic & Toil.
117(3):43-50.Roeske, R. (1963). Preparation of t-butyl esters of free amino
acids. J. Org. Chem. 28(5):1251-1253
9.
Idris, Z., Ahmad, S., Abu Hassan,
H., Yeong S.H. Samsudin, M.W. (2009). A method of producing derivative of
azelaic acid. Malaysian Patent Application. PI 2009 1437.